The first ever early clinical trial for a vaccine for genital chlamydia has shown it to be safe and effective at provoking an immune response The latest findings, from a randomised controlled trial of 35 healthy women led by Imperial College London and the Statens Serum Institut in Copenhagen, demonstrate promising early signs of what could be […]
InnovationPartnership The Institute of Cancer Research joins Imperial College Academic Health Science Centre
Imperial College Academic Health Science Centre (AHSC) is a strategic university-NHS partnership that aims to accelerate the translation of scientific breakthroughs into innovative ways to provide patient care. Formed in 2007, Imperial College AHSC was the UK’s first such centre, subsequently gaining Department of Health and Social Care designation. Its current members are Imperial College […]
DeviceFirst in HumanInnovationPartnershipTherapeutic Industry collaboration aims to improve prostate cancer surgery precision
A new project led by Imperial College London could help surgeons to visualise tumours during keyhole surgery, making the treatment more precise. Researchers at the College’s Institute of Global Health Innovation (IGHI) and NIHR Imperial BRC Surgery & Technology Theme will enhance an existing surgical probe developed by Lightpoint Medical, to generate ‘visual heat maps’ […]
One in 20 people worldwide has Type 2 Diabetes (T2D), with South Asians being more susceptible to the disease in comparison to Europeans. People with T2D have higher blood sugar levels than normal, which can increase the chances of developing long-term complications such as blindness, kidney disease, and heart failure. The first approach to managing […]
Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially come back to life years after initial treatment. The Imperial research team, who studied a group of breast cancer drugs called hormone treatments, say their research opens avenues for finding ways of keeping the cancer cells dormant for longer, or […]
Researchers from the Imperial Departments of Chemistry and Medicine have teamed up to tackle the threat posed by antibiotic-resistant bacteria. Supported by the EPSRC EMBRACE initiative, an Imperial Confidence in Concept award, and the NIHR Imperial BRC, members of Professor Ed Tate’s group (Chemistry) have been working closely with the group of Dr Andy Edwards […]
DiagnosticInnovationTherapeutic White matter affects how people respond to brain stimulation therapy
Tiny changes in the microscopic structure of the human brain may affect how patients respond to an emerging therapy for neurological problems. The technique, called non-invasive electrical brain stimulation, involves applying an electrical current to the surface of a patient’s head to stimulate brain cells, altering the patient’s brain activity. It is being trialled for […]
Harnessing world-leading discovery science and clinical expertise to develop innovative therapeutics, devices and diagnostics for healthcare
Examples of research projects testing out new drugs, devices and diagnostics in humans for the first time. The BRC is specifically aimed at supporting these kinds of experimental medicine studies.
The NIHR Imperial BRC has developed a range of innovative device technologies, in collaboration with scientists in our Faculties of Natural Sciences and Engineering. Some of the most recent are highlighted here.
The NIHR Imperial BRC has a strong, successful track record of collaborating with life sciences and other related industries, academic institutions, charities and research organisations. Most recent examples can be found here.